Regeneron’s Gene Therapy Improves Auditory Responses in Children with Genetic Hearing Loss
Regeneron’s trial investigating otoferlin gene therapy (DB-OTO) represents it's first auditory program and is currently enrolling patients.
Regeneron’s trial investigating otoferlin gene therapy (DB-OTO) represents it's first auditory program and is currently enrolling patients.